Sanara MedTech/$SMTI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sanara MedTech
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Ticker
$SMTI
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
141
ISIN
US79957L1008
Website
Sanara MedTech Metrics
BasicAdvanced
$252M
-
-$1.34
1.33
-
Price and volume
Market cap
$252M
Beta
1.33
52-week high
$38.68
52-week low
$25.86
Average daily volume
34K
Financial strength
Current ratio
2.774
Quick ratio
2.454
Long term debt to equity
121.334
Total debt to equity
121.96
Interest coverage (TTM)
-1.51%
Profitability
EBITDA (TTM)
-1.88
Gross margin (TTM)
91.17%
Net profit margin (TTM)
-12.48%
Operating margin (TTM)
-6.90%
Revenue per employee (TTM)
$650,000
Management effectiveness
Return on assets (TTM)
-4.72%
Return on equity (TTM)
-29.22%
Valuation
Price to revenue (TTM)
2.639
Price to book
6.89
Price to tangible book (TTM)
-28.23
Price to free cash flow (TTM)
-104.423
Free cash flow yield (TTM)
-0.96%
Free cash flow per share (TTM)
-27.16%
Growth
Revenue change (TTM)
34.65%
Earnings per share change (TTM)
128.74%
3-year revenue growth (CAGR)
50.34%
10-year revenue growth (CAGR)
40.92%
3-year earnings per share growth (CAGR)
0.80%
10-year earnings per share growth (CAGR)
-5.14%
What the Analysts think about Sanara MedTech
Analyst ratings (Buy, Hold, Sell) for Sanara MedTech stock.
Sanara MedTech Financial Performance
Revenues and expenses
Sanara MedTech News
AllArticlesVideos
Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)
GlobeNewsWire·1 month ago
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025
GlobeNewsWire·2 months ago
Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sanara MedTech stock?
Sanara MedTech (SMTI) has a market cap of $252M as of June 27, 2025.
What is the P/E ratio for Sanara MedTech stock?
The price to earnings (P/E) ratio for Sanara MedTech (SMTI) stock is 0 as of June 27, 2025.
Does Sanara MedTech stock pay dividends?
No, Sanara MedTech (SMTI) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Sanara MedTech dividend payment date?
Sanara MedTech (SMTI) stock does not pay dividends to its shareholders.
What is the beta indicator for Sanara MedTech?
Sanara MedTech (SMTI) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.